GRAIL, LLC: GRAIL Presents New Data Demonstrating That Methy

GRAIL's Methylation Assay Had 92% Cancer Detection Rate Across Six Hematologic Malignancies With 96% Accuracy in Determining the Hematologic Malignancy Subtype Findings Support Use of GRAIL's Methylation

Related Keywords

North Carolina , United States , United Kingdom , Washington , American , Jeffrey Venstrom , Cammy Duong , Trish Rowland , Nasdaq , Corporate Communications , Illumina Inc , Order Of The European Commission , American Association For Cancer Research , Assay Had , Hematologic Malignancy , Support Use , Identify Residual Disease , American Association , Cancer Research , Annual Meeting , Chief Medical Officer , Menlo Park , Interim Measures Order , Grail , Presents , Data , Emonstrating , Hat , Methylation , Essay , Detects , Residual , Aematologic , Dancer , After , Treatment , Association , Research , Racr , Nnual , Meeting , 023 ,